MALIGNANT MESOTHELIOMA
Clinical trials for MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody-chemo combo shows promise for mesothelioma
Disease control CompletedThis study tested a new drug called PM8002, which targets two proteins that help cancer grow, combined with standard chemotherapy. It involved 31 adults with a rare cancer called malignant mesothelioma that could not be removed by surgery. The goal was to see if the combination s…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: Biotheus Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Immune booster shows promise against rare cancer
Disease control CompletedThis study tested a drug called pembrolizumab in 65 people with malignant mesothelioma, a rare cancer of the lining around the lungs or abdomen. The drug works by helping the immune system attack cancer cells. The goal was to see if it could shrink tumors or slow the disease, but…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New Light-Measuring tool tested in cancer surgery
Disease control CompletedThis early-phase trial tested a light-measuring system used during photodynamic therapy (PDT) for people with malignant mesothelioma, non-small cell lung cancer, or other pleural cancers. Nine participants received the drug porfimer sodium, which becomes active when exposed to li…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC